Screener
IDEAYA Biosciences, Inc. IDYA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $157,522 | $112,825 |
| Short-term marketable securities | 513,679 | 526,563 |
| Prepaid expenses and other current assets | 18,346 | 21,366 |
| Contract assets | 6,560 | 5,973 |
| Total current assets | 696,107 | 666,727 |
| Restricted cash | 1,281 | 1,015 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s short-term investments?
- IDEAYA Biosciences, Inc. (IDYA) reported short-term investments of $513.68M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s short-term investments changed year-over-year?
- IDEAYA Biosciences, Inc.'s short-term investments decreased by 8.7% year-over-year, from $562.51M to $513.68M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s short-term investments has grown at a 20.0% compound annual growth rate (CAGR), from $211.55M to $526.56M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about IDEAYA Biosciences, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude